Brief: Rosetta Genomics Q2 non-gaap loss per share $0.15 excluding items
Sept 26 (Reuters) - Rosetta Genomics Ltd ROSG.O
* Rosetta genomics reports 2016 second quarter financial
results
* Q2 loss per share $0.16
* Q2 revenue rose 23 percent to $2.4 million
* Q2 earnings per share view $-0.17 -- Thomson Reuters
I/B/E/S
* Q2 non-gaap loss per share $0.15 excluding items
* "in q3 we expect approximately 300 reveal orders with
gross billings of approximately $900,000"
Source text for Eikon: ID:nBw9qwC9va
Further company coverage: ROSG.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics